Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiinflammatory effects of montelukast in cystic fibrosis

Jan. 31, 2003

First clinical study of IPL-512602 under way in the U.S.

Jan. 30, 2003

Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article

Jan. 30, 2003

NicOx and Biolipox expand research on NO-donating respiratory drugs

Jan. 30, 2003

GSK designs novel series of glucocorticoids

Jan. 29, 2003

New integrin antagonists with utility in asthma covered by Aventis patent

Jan. 28, 2003

Safety study of Serevent halted

Jan. 27, 2003

Bayer patents two series of PDE4 inhibitors for COPD and asthma

Jan. 27, 2003

New treatment option for COPD nearing approval in Europe

Jan. 24, 2003

Coley earns CpG-7279 milestone payment from Aventis

Jan. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.